References

  1. Smitherman TA, Burch R, Sheikh H, Loder E. The prevalence, impact, and treatment of migraine and severe headaches in the United States: a review of statistics from national surveillance studies. Headache. 2013;53(3):427-436.
  2. Lipton R, Bigal M, Diamond M, Freitag F, Reed M, Stewart W. Migraine prevalence, disease burden, and the need for preventive therapy. Neurology. 2007;68:343-349.
  3. Lipton R, Stewart A, Diamond S, Reed M. Prevalence and burden of migraine in the United States: data from the American Migraine Study II. Headache. 2001;41:646-657.
  4. Headache Classification Committee of the International Headache Society. The International Classification of Headache Disorders, 3rd edition (beta version). Cephalalgia. 2013;33(9):629-808.
  5. Leonardi M, Raggi A. Burden of migraine: international perspectives. Neurol Sci. 2013;34 Suppl 1:S117-S118.
  6. Blumenfeld AM, Varon SF, Wilcox TK, et al. Disability, HRQoL and resource use among chronic and episodic migraineurs: results from the International Burden of Migraine Study (IBMS). Cephalalgia. 2011;31(3):301-315.
  7. Serrano D, Manack AN, Reed ML, Buse DC, Varon SF, Lipton RB. Cost and predictors of lost productive time in chronic migraine and episodic migraine: results from the American Migraine Prevalence and Prevention (AMPP) Study. Value Health. 2013;16(1):31-38.
  8. Gil-Gouveia R, Oliveira AG, Martins IP. Assessment of cognitive dysfunction during migraine attacks: a systematic review. J Neurol. 2015;262(3):654-665.
  9. Seng EK, Holroyd KA. Optimal use of acute headache medication: a qualitative examination of behaviors and barriers to their performance. Headache. 2013;53(9):1438-1450.
  10. Katic BJ, Krause SJ, Tepper SJ, Hu HX, Bigal ME. Adherence to acute migraine medication: what does it mean, why does it matter? Headache. 2010;50(1):117-129.
  11. Seng EK, Rains JA, Nicholson RA, Lipton RB. Improving medication adherence in migraine treatment. Curr Pain Headache Rep. 2015;19(6):24.
  12. Suhr JA, Seng EK. Neuropsychological functioning in migraine: clinical and research implications. Cephalalgia. 2012;32(1):39-54.
  13. Silberstein SD. Topiramate in migraine prevention: A 2016 perspective. Headache. 2017;57(1):165-178.
  14. Houle TT, Turner DP. Natural experimentation is a challenging method for identifying headache triggers. Headache. 2013;53(4):636-643.
  15. Peris F, Donoghue S, Torres F, Mian A, Wober C. Towards improved migraine management: Determining potential trigger factors in individual patients [published online May 14, 2016]. Cephalalgia. 2016; doi: 10.1177/0333102416649761
  16. Martin PR, Reece J, Callan M, et al. Behavioral management of the triggers of recurrent headache: a randomized controlled trial. Behav Res Ther. 2014;61:1-11.
  17. Martin PR. Behavioral management of migraine headache triggers: learning to cope with triggers. Curr Pain Headache Rep. 2010;14(3):221-227.
  18. Martin PR. Managing headache triggers: think ‘coping’ not ‘avoidance’. Cephalalgia. 2010;30(5):634-637.
  19. Leeuw M, Goossens ME, Linton SJ, Crombez G, Boersma K, Vlaeyen JW. The fear-avoidance model of musculoskeletal pain: current state of scientific evidence. J Behav Med. 2007;30(1):77-94.
  20. French DJ, France CR, Vigneau F, French JA, Evans RT. Fear of movement/(re)injury in chronic pain: a psychometric assessment of the original English version of the Tampa scale for kinesiophobia (TSK). Pain. 2007;127(1-2):42-51.
  21. Black AK, Fulwiler JC, Smitherman TA. The role of fear of pain in headache. Headache. 2015;55(5):669-679.
  22. Wober C, Wober-Bingol C. Triggers of migraine and tension-type headache. Handb Clin Neurol. 2010;97:161-172.
  23. Todd DD, Martelli MF, Grayson RL. The Cogniphobia Scale (C-scale). www.angelfire.com/va/MFMartelliPhD/nanposters.html. Accessed January 13, 2017.
  24. Suhr JA, Spickard B. Pain-related fear is associated with cognitive task avoidance: exploration of the cogniphobia construct in a recurrent headache sample. Clin Neuropsychol. 2012;26(7):1128-1141.
  25. Seng EK, Rains JA, Nicholson RA, Lipton RB. Improving medication adherence in migraine treatment. Curr Pain Headache Rep. 2015;19(6):24.
  26. Seng EK, Klepper J. Development of the cogniphobia scale for headache disorders (CS-HD): a pilot study. Psychol Assess. In press.
  27. Klepper J, Mayson SJ, Pavlovic J, Seng EK. Cogniphobia associated with increased pain anxiety, general anxiety, depression and migraine-related disability in adults with migraine. 123rd Annual Convention of the American Psychological Association. August 6-9, 2015, Toronto, Ontario, Canada; 2015.
  28. Wertli MM, Rasmussen-Barr E, Held U, Weiser S, Bachmann LM, Brunner F. Fear-avoidance beliefs-a moderator of treatment efficacy in patients with low back pain: a systematic review. Spine J. 2014;14(11):2658-2678.